Opportunities for Collaboration Continue to Draw Independent Large and Small Practices From Across the CountryPUYALLUP, WA / ACCESSWIRE / October…
Advarra's Gene Therapy Ready (GTR) global site network expands to better support and accelerate the rapidly growing number of CGT…
Dr. Mignone's expert ENT approach brings innovative VivAer® nasal relief to New Jersey residents.ROBBINSVILLE, NJ / ACCESSWIRE / October 3,…
Robert Edwards, MD, UPMC, Magee-Womens Hospital Robert Edwards, MD, UPMC, Magee-Womens Hospital Thomas Equels, CEO of AIM ImmunoTech Inc Thomas…
Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates…
Former Eli Lilly Research Fellow Jeremy R. Graff, Ph.D., appointed as President and Chief Development Officer to lead the Company’s clinical…
NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader…
DSMC has reviewed the safety and pharmacokinetic data from Cohort 2 and recommended that the study proceed to enroll patients…
The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting…
Media Release SYDNEY, AUSTRALIA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”),…